Skip to content
healthcare.dev

Wing Scale Pollen

NDC 49643-438, Atriplex canescens, injection, from Allermed Laboratories, Inc..

Product NDC
49643-438
Status
Listed
Labeler
Allermed Laboratories, Inc.
Dosage form
INJECTION
Route
CUTANEOUS, INTRADERMAL, SUBCUTANEOUS
Product type
NON-STANDARDIZED ALLERGENIC
Marketing category
BLA
Application
BLA102211
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/49643-438 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATRIPLEX CANESCENS POLLEN.05 g/mL

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]

Package NDCNDC-11Package
49643-438-05496430438055 mL in 1 VIAL, MULTI-DOSE (49643-438-05)
49643-438-104964304381010 mL in 1 VIAL, MULTI-DOSE (49643-438-10)
49643-438-304964304383030 mL in 1 VIAL, MULTI-DOSE (49643-438-30)
49643-438-504964304385050 mL in 1 VIAL, MULTI-DOSE (49643-438-50)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 49643-438 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/49643-438 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 49643-438. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.